Year
DEALS // DEV.
Country
Therapeutic Area
Study Phase
Deal Type
Product Type
Dosage Form
Lead Product
Target
Lead Product(s) : CAR-T cell therapy
Therapeutic Area : Oncology
Study Phase : Undisclosed
Sponsor : Orgenesis
Deal Size : Undisclosed
Deal Type : Collaboration
Orgenesis Enters Collaboration Agreement with Educell
Details : The agreement is part of the Orgenesis strategy of growing and expanding the POCare Network. The first collaboration under the agreement will focus on the clinical development of CAR-T and whole cell-based vaccine platform for use in cancer immunotherapi...
Brand Name : Undisclosed
Molecule Type : Cell and Gene therapy
Upfront Cash : Undisclosed
July 14, 2020
Lead Product(s) : CAR-T cell therapy
Therapeutic Area : Oncology
Highest Development Status : Undisclosed
Sponsor : Orgenesis
Deal Size : Undisclosed
Deal Type : Collaboration
LOOKING FOR A SUPPLIER?
Reset All
